Nucleic Acid Isolation and Purification Market Size, Share, Growth, Trends and Forecast Reportby Susan Hill Business Consultant
The global nucleic acid isolation and purification market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Nucleic acid isolation is the most basic step deployed in sequencing technologies. Increasing employment of next-generation sequencing (NGS) techniques along with the declining cost of genomic sequencing drives the market.
Ongoing developments of automated nucleic acid extraction systems designed for high-throughput sample processing have significantly simplified the isolation of DNA and RNA, thereby providing lucrative avenues for market growth. These systems potentially reduce the labor costs and time, increase worker safety, laboratory efficiency, reproducibility, and quality of results.
The growing popularity of biopharmaceuticals has led to the development of nucleic acid-based products, such as DNA vaccines, small interfering RNA, and antisense oligonucleotides. These products are applied in therapeutic techniques, such as gene therapy and anti-sense technology, as a powerful tool for medical practitioners to treat cancer, genetic, and infectious diseases. This has boosted the adoption of DNA or RNA isolation techniques in the market.
Further key findings from the report suggest:
- The instruments segment is expected to
grow at a lucrative pace due to the advent of automated extraction systems
resulting in high performance and lower cost for DNA extraction
- DNA isolation methods accounted for the
largest revenue share and are anticipated to witness the fastest progress
rate due to ongoing discoveries of simple, rapid, and inexpensive methods
- The high adoption rate of magnetic bead
methods is attributive to its largest revenue share
- This is because the method can isolate
nucleic acids directly from the crude sample without much processing
- This method is also expected to witness
the fastest CAGR owing to the development of functionalized magnetic
particles that have been incorporated in buffer systems to provide rapid
and efficient extraction
- Oncology application is projected to
witness a lucrative growth rate as liquid biopsy techniques and
patient-tailored therapies are gaining traction for cancer diagnosis
- Hospitals and diagnostic centers
accounted for the largest share in 2019, in terms of revenue
- The high incidence rate of genetic and
inherited diseases has increased the usage of nucleic acid isolation in
early and accurate diagnosis of these conditions in hospitals
- Better healthcare infrastructure, a
substantial number of technology providers, and rapid adoption of NGS has
driven the uptake of nucleic acid extraction products in North America at
a large scale
- Asia Pacific is anticipated to exhibit
the fastest CAGR over the forecast period owing to significant public and
private commitments towards genomics research and precision
medicine, thereby prompting the adoption of isolation techniques
- QIAGEN, Agilent Technologies, Danaher, Illumina, Roche, and Thermo Fisher are some key companies operating in the nucleic acid isolation and purification market.
Access full research report on global nucleic
acid isolation and purification market:
Created on Apr 10th 2020 05:10. Viewed 86 times.